The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy

Anderson-Fabry disease (AFD) is an X-linked disorder caused by deficient activity of the lysosomal enzyme α-galactosidase A. The availability of enzyme replacement therapy (ERT) for this debilitating condition has led to the need for a convenient and sensitive instrument to monitor clinical effects...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Whybra-Trümpler, Catharina (VerfasserIn) , Kampmann, Christoph (VerfasserIn) , Krummenauer, Frank (VerfasserIn) , Ries, Markus (VerfasserIn) , Mengel, Eugen (VerfasserIn) , Miebach, Elke (VerfasserIn) , Baehner, Frank (VerfasserIn) , Kim, K. (VerfasserIn) , Bajbouj, M. (VerfasserIn) , Schwarting, Andreas (VerfasserIn) , Gal, Andreas (VerfasserIn) , Beck, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 16 February 2004
In: Clinical genetics
Year: 2004, Jahrgang: 65, Heft: 4, Pages: 299-307
ISSN:1399-0004
DOI:10.1111/j.1399-0004.2004.00219.x
Online-Zugang:Verlag, Volltext: https://doi.org/10.1111/j.1399-0004.2004.00219.x
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-0004.2004.00219.x
Volltext
Verfasserangaben:C Whybra, C Kampmann, F Krummenauer, M Ries, E Mengel, E Miebach, F Baehner, K Kim, M Bajbouj, A Schwarting, A Gal and M Beck

MARC

LEADER 00000caa a2200000 c 4500
001 1665839457
003 DE-627
005 20230427160249.0
007 cr uuu---uuuuu
008 190516s2004 xx |||||o 00| ||eng c
024 7 |a 10.1111/j.1399-0004.2004.00219.x  |2 doi 
035 |a (DE-627)1665839457 
035 |a (DE-599)KXP1665839457 
035 |a (OCoLC)1341224852 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Whybra-Trümpler, Catharina  |d 1974-  |e VerfasserIn  |0 (DE-588)124450814  |0 (DE-627)363357351  |0 (DE-576)294177841  |4 aut 
245 1 4 |a The Mainz Severity Score Index  |b a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy  |c C Whybra, C Kampmann, F Krummenauer, M Ries, E Mengel, E Miebach, F Baehner, K Kim, M Bajbouj, A Schwarting, A Gal and M Beck 
264 1 |c 16 February 2004 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.05.2019 
520 |a Anderson-Fabry disease (AFD) is an X-linked disorder caused by deficient activity of the lysosomal enzyme α-galactosidase A. The availability of enzyme replacement therapy (ERT) for this debilitating condition has led to the need for a convenient and sensitive instrument to monitor clinical effects in an individual patient. This study aimed to develop a scoring system - the Mainz Severity Score Index (MSSI) - to measure the severity of AFD and to monitor the clinical course of the disease in response to ERT. Thirty-nine patients (24 males and 15 females) with AFD were assessed using the MSSI immediately before and 1 year after commencing agalsidase alfa ERT. Control data were obtained from 23 patients in whom AFD was excluded. The MSSI of patients with AFD was significantly higher than that of patients with other severe debilitating diseases. The MSSI indicated that, although more men than women had symptoms classified as severe, overall, the median total severity scores were not significantly different between male and female patients. One year of ERT with agalsidase alfa led, in all patients, to a significant (p < 0.001) reduction in MSSI score (by a median of nine points). This study has shown that the MSSI score may be a useful, specific measure for objectively assessing the severity of AFD and for monitoring ERT-related treatment effects. 
650 4 |a Anderson-Fabry disease 
650 4 |a enzyme replacement therapy 
650 4 |a Mainz Severity Score Index 
650 4 |a α-galactosidase A 
700 1 |a Kampmann, Christoph  |d 1959-  |e VerfasserIn  |0 (DE-588)115473645  |0 (DE-627)691343810  |0 (DE-576)289903203  |4 aut 
700 1 |a Krummenauer, Frank  |d 1969-  |e VerfasserIn  |0 (DE-588)172983916  |0 (DE-627)697909778  |0 (DE-576)13383736X  |4 aut 
700 1 |a Ries, Markus  |d 1971-  |e VerfasserIn  |0 (DE-588)136385338  |0 (DE-627)582068479  |0 (DE-576)300993358  |4 aut 
700 1 |a Mengel, Eugen  |d 1963-  |e VerfasserIn  |0 (DE-588)135623901  |0 (DE-627)56860427X  |0 (DE-576)300550545  |4 aut 
700 1 |a Miebach, Elke  |d 1975-  |e VerfasserIn  |0 (DE-588)133021114  |0 (DE-627)530936100  |0 (DE-576)29956987X  |4 aut 
700 1 |a Baehner, Frank  |d 1972-  |e VerfasserIn  |0 (DE-588)123046718  |0 (DE-627)706140001  |0 (DE-576)293533555  |4 aut 
700 1 |a Kim, K.  |e VerfasserIn  |4 aut 
700 1 |a Bajbouj, M.  |e VerfasserIn  |4 aut 
700 1 |a Schwarting, Andreas  |e VerfasserIn  |0 (DE-588)1161391479  |0 (DE-627)1024706222  |0 (DE-576)506496406  |4 aut 
700 1 |a Gal, Andreas  |e VerfasserIn  |0 (DE-588)1027463312  |0 (DE-627)72916618X  |0 (DE-576)373240260  |4 aut 
700 1 |a Beck, Michael  |d 1947-2022  |e VerfasserIn  |0 (DE-588)132550423  |0 (DE-627)523640226  |0 (DE-576)189101768  |4 aut 
773 0 8 |i Enthalten in  |t Clinical genetics  |d Oxford : Wiley-Blackwell, 1970  |g 65(2004), 4, Seite 299-307  |h Online-Ressource  |w (DE-627)320437949  |w (DE-600)2004581-5  |w (DE-576)091142628  |x 1399-0004  |7 nnas  |a The Mainz Severity Score Index a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy 
773 1 8 |g volume:65  |g year:2004  |g number:4  |g pages:299-307  |g extent:9  |a The Mainz Severity Score Index a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy 
856 4 0 |u https://doi.org/10.1111/j.1399-0004.2004.00219.x  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-0004.2004.00219.x  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190516 
993 |a Article 
994 |a 2004 
998 |g 136385338  |a Ries, Markus  |m 136385338:Ries, Markus  |p 4 
999 |a KXP-PPN1665839457  |e 3476618951 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 16.05.2019"],"recId":"1665839457","title":[{"title_sort":"Mainz Severity Score Index","title":"The Mainz Severity Score Index","subtitle":"a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy"}],"id":{"eki":["1665839457"],"doi":["10.1111/j.1399-0004.2004.00219.x"]},"relHost":[{"recId":"320437949","pubHistory":["1.1970 -"],"note":["Gesehen am 19.05.08"],"disp":"The Mainz Severity Score Index a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapyClinical genetics","id":{"issn":["1399-0004"],"doi":["10.1111/(ISSN)1399-0004"],"eki":["320437949"],"zdb":["2004581-5"]},"title":[{"title":"Clinical genetics","title_sort":"Clinical genetics"}],"language":["eng"],"origin":[{"publisherPlace":"Oxford ; Malden, Mass. ; Copenhagen ; Oxford [u.a.]","dateIssuedKey":"1970","dateIssuedDisp":"1970-","publisher":"Wiley-Blackwell ; Wiley ; Munksgaard ; Blackwell"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"pages":"299-307","year":"2004","extent":"9","issue":"4","volume":"65","text":"65(2004), 4, Seite 299-307"},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"9 S."}],"person":[{"family":"Whybra-Trümpler","roleDisplay":"VerfasserIn","given":"Catharina","display":"Whybra-Trümpler, Catharina","role":"aut"},{"role":"aut","display":"Kampmann, Christoph","given":"Christoph","roleDisplay":"VerfasserIn","family":"Kampmann"},{"role":"aut","display":"Krummenauer, Frank","given":"Frank","roleDisplay":"VerfasserIn","family":"Krummenauer"},{"given":"Markus","display":"Ries, Markus","role":"aut","family":"Ries","roleDisplay":"VerfasserIn"},{"family":"Mengel","roleDisplay":"VerfasserIn","given":"Eugen","role":"aut","display":"Mengel, Eugen"},{"roleDisplay":"VerfasserIn","family":"Miebach","display":"Miebach, Elke","role":"aut","given":"Elke"},{"display":"Baehner, Frank","role":"aut","given":"Frank","family":"Baehner","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Kim","given":"K.","role":"aut","display":"Kim, K."},{"roleDisplay":"VerfasserIn","family":"Bajbouj","given":"M.","role":"aut","display":"Bajbouj, M."},{"display":"Schwarting, Andreas","role":"aut","given":"Andreas","roleDisplay":"VerfasserIn","family":"Schwarting"},{"display":"Gal, Andreas","role":"aut","given":"Andreas","family":"Gal","roleDisplay":"VerfasserIn"},{"family":"Beck","roleDisplay":"VerfasserIn","given":"Michael","role":"aut","display":"Beck, Michael"}],"name":{"displayForm":["C Whybra, C Kampmann, F Krummenauer, M Ries, E Mengel, E Miebach, F Baehner, K Kim, M Bajbouj, A Schwarting, A Gal and M Beck"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2004","dateIssuedDisp":"16 February 2004"}],"language":["eng"]} 
SRT |a WHYBRATRUEMAINZSEVER1620